Q&A: Morgan Stanley Investment Management’s Patrick Reid
Patrick Reid, a UK-based managing director for alternatives distribution management at Morgan Stanley Investment Management, plots the future of themes around secondaries, longer holds, and hybrid approaches to PE
Q: What are you seeing in the secondaries market? A: From the numbers we have seen, the secondaries market has tripled since 2011 and reached well over USD 100bn for the first time this year. The GP-led...
Co-Stone leads $43m round for China biosynthesis player
Co-Stone Capital Management has led a CNY 300m (USD 43m) Series B round for Readline, a Shenzhen-based company that specialises in synthetic biology.
Australia’s Heal Partners closes debut fund on $137m
Australia’s Heal Partners, a health, education, and lifestyle-focused venture capital firm, has closed its first fund on AUD 200m (USD 137m). The target was AUD 100m.
US regulator gets access to Chinese audits
The threat of delisting that has haunted Chinese companies that trade on US exchanges appears to have receded after the US regulators announced they had gained full access to the audits of these companies for the first time.